(92 days)
Not Found
No
The description details a standard immunoassay (lateral flow test) which relies on chemical reactions and visual interpretation, with no mention of AI/ML terms or processes.
No
The device is a diagnostic test for detecting pregnancy, not a therapeutic device designed to treat or prevent a disease or condition.
Yes
The device is described as an aid in the diagnosis of early pregnancy, indicating its use in identifying a medical condition.
No
The device description clearly indicates it is a physical, single-use cassette test that is visually read, which is a hardware component.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for the "detection of human chorionic gonadotropin (hCG) in urine for the early detection of pregnancy." This is a test performed on a biological sample (urine) outside of the body to provide information about a physiological state (pregnancy).
- Device Description: The description details a "qualitative immunoassay" and a "lateral flow immuno-Chromatographic test." These are common techniques used in IVD devices to detect specific substances in biological samples.
- Indication for Use: The indication for use is "as an aid in the diagnosis of early pregnancy," which is a diagnostic purpose.
- Intended User / Care Setting: While it's for "laboratory and professional use only," this still falls under the scope of IVD use, which can be performed in various professional healthcare settings.
The core function of the device is to analyze a biological sample (urine) in vitro (outside the body) to provide diagnostic information (pregnancy detection). This aligns perfectly with the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Instant-View TM Pregnancy Urine Test is designed for qualitative detection of the human chorionic gonadotropin (hCG) in urine. The test is for use as an aid in the diagnosis of early pregnancy.
The Instant-View Pregnancy Urine Test is a qualitative immunoassay for the detection of human chorionic gonadotropin (hCG) in urine for the early detection of pregnancy.
This test is for laboratory and professional use only.
Product codes (comma separated list FDA assigned to the subject device)
75 JHI
Device Description
A single step, visually read, qualitative chromatographic immunoassay, single use cassette test
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
laboratory and professional use only.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The accuracy by correlation of the results from the Instant-ViewTM Pregnancy Urine Test and the legally marketed test is 100%, indicating that the Instant-ViewTM Pregnancy Urine Test is substantially equivalent to this existing legally marketed product.
The evaluation results from a clinical lab and three physician's offices conducted by the persons with diverse educational backgrounds and working experience agreed 100% with the results expected.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1155 Human chorionic gonadotropin (HCG) test system.
(a)
Human chorionic gonadotropin (HCG) test system intended for the early detection of pregnancy —(1)Identification. A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class II.(b)
Human chorionic gonadotropin (HCG) test system intended for any uses other than early detection of pregnancy —(1)Identification. A human chorionic goadotropin (HCG) test system is a device intended for any uses other than early detection of pregnancy (such as an aid in the diagnosis, prognosis, and management of treatment of persons with certain tumors or carcinomas) is intended to measure HCG, a placental hormone, in plasma or urine.(2)
Classification. Class III.(3)
Date PMA or notice of completion of a PDP is required. As of the enactment date of the amendments, May 28, 1976, an approval under section 515 of the act is required before the device described in paragraph (b)(1) may be commercially distributed. See § 862.3.
0
Image /page/0/Picture/0 description: The image shows the logo for Alfa Scientific Designs, Inc. The logo is a stylized "AA" symbol. Above the logo is the date 2/16/99.
Medical Diagnostic Devices. Contract R&D. OEM 11494 Sorrento Valley Rd, Suite F & M San Diego, CA 92121 Tel: (619) 350-9798 Fax: (619) 350-9709
E-mail: asdi@worldnet.att.net 510(K) Summary (K984076)
Submitter
Name and address: Alfa Scientific Designs, Inc. 11494 Sorrento Valley Rd, Suite M San Diego, CA 92121 619-350-9798 (Tel) 619-350-9709 (Fax)
Contact Person: Naishu Wang, MD, Ph.D.
Date Prepared: 12/30/98
Device Name
Trade Name: Instant-View™ Pregnancy Urine Test
Common Name: Human Chorionic Gonadotropin (hCG) Test
Classification name: 21CFR section 862.1155, Class II. A Qualitative Human Chorionic Gonadotropin (hCG) test system.
Predicate device
The Instant-View Pregnancy Urine Test is substantially equivalent to other legally marketed devices for the similar intended use. The device used for comparison study is OSOM Pregnancy Urine Test made by Wyntek Diagnostic, Inc., 510K#: K953383.
Device description
Intended use
A single step, visually read, qualitative chromatographic immunoassay, single use cassette test
The Instant-View TM Pregnancy Urine Test is designed for qualitative detection of the human chorionic gonadotropin (hCG) in urine. The test is for use as an aid in the diagnosis of early pregnancy.
510(K) Summary
Continued on next page
1
:
| Summary of the
similarities to the
predicate device | ● | The intended use and performance characteristics:
Both devices are intended to use for an early detection of hCG
in human urine at the level close to 25 mIU/ml (OSOM claimed
a sensitivity to hCG as low as 30 mIU/ml) or greater (calibrated
against the WHO 3rd IS 75/537). |
|-----------------------------------------------------------|---|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | ● | Technological characteristics:
Both devices are one step, qualitative, visual lateral flow
immuno-Chromatographic test in a sandwich complex format of
anti-hCG antibody /hCG/ anti-hCG antibody. |
| | ● | Interpretation of results:
The presence of C line serves as an internal quality control, and
the presence of the T line indicates a positive result. |
| Discussion and
Conclusion | ● | The accuracy by correlation of the results from the Instant-
ViewTM Pregnancy Urine Test and the legally marketed test is
100%, indicating that the Instant-ViewTM Pregnancy Urine
Test is substantially equivalent to this existing legally marketed
product. |
| | ● | The evaluation results from a clinical lab and three physician's
offices conducted by the persons with diverse educational
backgrounds and working experience agreed 100% with the
results expected. |
| | ● | Based on the results of the correlation and POL studies, we may
conclude that the Instant-ViewTM Pregnancy Urine Test is as
safe, as effective, and performs as well as the legally marketed
device. Therefore, this test is suitable for use by health care
professionals with diverse educational backgrounds and work
experience. |
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of a human figure in profile, with the head, shoulders, and upper torso represented by a series of curved lines. The figure is positioned within a circular border, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper portion of the circle.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
FEB 1 6 1999
Naishu Wang, M.D., Ph.D. President Alfa Scientific Designs, Inc. 11494 Sorrento Valley Road, Suite F&M San Diego, CA 92121
Re: K984076
Trade Name: Instant-View Pregnancy Urine Test Regulatory Class: II Product Code: 75 JHI Dated: January 6, 1999 Received: January 11, 1999
Dear Dr. Wang:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Ouality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic OS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition. FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770)488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll free number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html"
Sincerely yours,
Steven Autman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Page 14 of 14
| Labels | Values |
|---|---|
| 510(k) Number (if known) | K984076 |
| Device Name | Instant-View pregnancy Urine Test |
Indications For Use:
The Instant-View Pregnancy Urine Test is a qualitative immunoassay for the detection of human chorionic gonadotropin (hCG) in urine for the early detection of pregnancy.
This test is for laboratory and professional use only.
( 1 ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( 1 ) ( (Division Sign-Off)
Division of Clinical Labora 510(k) Number_ 关
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use__________________________________________________________________________________________________________________________________________________________
(Optional Format 1-2-96)